China CDC

China CDC
China CDC Weekly
Articles in Press [Selected]
Notes from the Field: Emerging Variants of B.1.617 Lineage Identified Among Returning Chinese Employees Working in India — Chongqing Municipality, China, April 2021

Technical Vaccination Recommendations for COVID-19 Vaccines in China (First Edition)
Online Date: March 31 2021

National Health Commission of the People’s Republic of China [to 1 May 2021]
May 1: Daily briefing on novel coronavirus cases in China
On April 30, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 16 new cases of confirmed infections.

China continues measures to control imported COVID cases
Updated: 2021-04-30
China will continue to take strict measures to prevent imported COVID-19 infections via people or goods after several inbound travelers tested positive for novel coronavirus after finishing quarantine, a senior health official said on April 29.
Wang Bin, a senior official at the National Health Commission, said the commission requires all inbound travelers to take nucleic acid tests during quarantine.
At the end of the 14-day medical quarantine, they should receive nucleic acid tests from at least two institutions to increase the accuracy of the tests, she said at a news conference.
After they finish the 14-day medical quarantine, they should observe seven-day home health monitoring, take necessary epidemic containment measures when going out and avoid large gatherings, she said…

National Medical Products Administration – PRC [to 1 May 2021]
Vice-premier stresses production, supply of COVID-19 vaccines
Vice-Premier Sun Chunlan on April 29 called for speeding up the production and supply of COVID-19 vaccines, ensuring quality and safety and promoting vaccination among the public to build an immune barrier.

Over 243 million COVID-19 vaccine doses administered across China
More than 243.9 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission said on April 29.

China’s new recombinant COVID-19 vaccine starts human tests
Chinese pharmaceutical giant Sinopharm has commenced phase-1 and phase-2 clinical trials for its new recombinant vaccine against COVID-19 in Central China’s Henan province since April 24.